The tweet was deleted by the author.
But we saved everything 🙂.
Amgen has announced that it will release its financial results for the third quarter of 2025 on Tuesday, November 4.
This announcement is likely to draw significant interest from investors and market analysts seeking insights into the company's performance during this period. Amgen, known for its innovations in biotechnology, provides crucial data that can influence market perceptions and investor decisions. More detailed financial information will be available once the results are published, offering a comprehensive view of the company's quarterly achievements and strategic positioning.
The upcoming financial disclosure will be closely watched, especially as Amgen continues to adapt its strategies in a competitive landscape. This focus on performance follows the company’s recent initiatives to expand accessibility, including the introduction of AmgenNow offering 60 percent reduced CV drug prices, a move that highlights Amgen's ongoing efforts to balance innovation with affordability.